Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens
- Author
- MONTESINOS, Pau1 ; RAYON, Chelo2 ; RIVAS, Concha11 ; TORMO, Mar12 ; RUBIO, Vicente13 ; BUENO, Javier14 ; MANSO, Félix15 ; MILONE, Gustavo16 ; DE LA SERNA, Javier17 ; PEREZ, Inmaculada18 ; PEREZ-ENCINAS, Manuel19 ; KRSNIK, Isabel20 ; VELLENGA, Edo3 ; RIBERA, Josep M21 ; ESCODA, Lourdes22 ; LOWENBERG, Bob23 ; SANZ, Miguel A1 ; BRUNET, Salut4 ; GONZALEZ, José5 ; GONZALEZ, Marcos6 ; HOLOWIECKA, Aleksandra7 ; ESTEVE, Jordi8 ; BERGUA, Juan9 ; GONZALEZ, José D10
[1] Hospital Universitario La Fe, Valencia, Spain
[2] Hospital Central de Asturias, Oviedo, Spain
[3] University Hospital, Groningen, Netherlands
[4] Hospital Sant Pau, Barcelona, Spain
[5] Hospital Universitario Virgen del Rocío, Sevilla, Spain
[6] Hospital Universitario, Salamanca, Spain
[7] M. Sklodowska-Curie Memorial Institute, Gliwice, Poland
[8] Hospital Clinic, Barcelona, Spain
[9] Hospital San Pedro de Alcántara, Cáceres, Spain
[10] Hospital Insular, Las Palmas, Spain
[11] Hospital General, Alicante, Spain
[12] Hospital Clínico Universitario, Valencia, Spain
[13] Hospital General, Jerez de la Frontera, Spain
[14] Hospital Universitario Valle d'Hebron, Barcelona, Spain
[15] Hospital General, Albacete, Spain
[16] Fundaleu, Buenos Aires, Argentina
[17] Hospital 12 de Octubre, Madrid, Spain
[18] Hospital Universitario Virgen de la Victoria, Malaga, Spain
[19] Hospital Clínico Universitario, Santiago de Compostela, Spain
[20] Hospital Puerta de Hierro, Madrid, Spain
[21] Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
[22] Hospital Joan XXIII, Tarragona, Spain
[23] Erasmus University Medical Center, Rotterdam, Netherlands
PETHEMA and HOVON Groups - Source
Blood. 2011, Vol 117, Num 6, pp 1799-1805, 7 p ; ref : 29 ref
- ISSN
- 0006-4971
- Scientific domain
- Medical oncology; Hematology
- Publisher
- Americain Society of Hematology, Washington, DC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Aigu Anthracyclines Anticancéreux Cellule NK Homme Hématologie Leucémie myéloblastique M3 Leucémie promyélocytaire Protocole thérapeutique Protéine NCAM Traitement Trétinoïne Cancer Hémopathie maligne Rétinoïde
- Keyword (en)
- Acute Anthracyclins Antineoplastic agent Natural killer cell Human Hematology M3 acute myelocytic leukemia Promyelocytic leukemia Therapeutic protocol Neural cell adhesion molecule Treatment Tretinoin Cancer Malignant hemopathy Retinoid
- Keyword (es)
- Agudo Antraciclinas Anticanceroso Célula NK Hombre Hematología Leucemia mieloblástica M3 Leucemia promielocítica Protocolo terapéutico Proteína NCAM Tratamiento Tretinoína Cáncer Hemopatía maligna Retinoide
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 23842671
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1182/blood-2010-04-277434 
https://dx.doi.org/10.1182/blood-2010-04-277434
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1182\/blood-2010-04-277434\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"117\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1799\";s:8:\"\u0000*\u0000epage\";s:4:\"1805\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"MONTESINOS\";s:10:\"\u0000*\u0000aufirst\";s:3:\"Pau\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:12:\"RAYON, Chelo\";i:1;s:13:\"RIVAS, Concha\";i:2;s:10:\"TORMO, Mar\";i:3;s:14:\"RUBIO, Vicente\";i:4;s:13:\"BUENO, Javier\";i:5;s:13:\"MANSO, F\u00e9lix\";i:6;s:15:\"MILONE, Gustavo\";i:7;s:19:\"DE LA SERNA, Javier\";i:8;s:17:\"PEREZ, Inmaculada\";i:9;s:21:\"PEREZ-ENCINAS, Manuel\";i:10;s:14:\"KRSNIK, Isabel\";i:11;s:13:\"VELLENGA, Edo\";i:12;s:15:\"RIBERA, Josep M\";i:13;s:15:\"ESCODA, Lourdes\";i:14;s:14:\"LOWENBERG, Bob\";i:15;s:14:\"SANZ, Miguel A\";i:16;s:13:\"BRUNET, Salut\";i:17;s:15:\"GONZALEZ, Jos\u00e9\";i:18;s:16:\"GONZALEZ, Marcos\";i:19;s:22:\"HOLOWIECKA, Aleksandra\";i:20;s:13:\"ESTEVE, Jordi\";i:21;s:12:\"BERGUA, Juan\";i:22;s:17:\"GONZALEZ, Jos\u00e9 D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:31:\"Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1182\/blood-2010-04-277434\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"117\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1799\";s:8:\"\u0000*\u0000epage\";s:4:\"1805\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"MONTESINOS\";s:10:\"\u0000*\u0000aufirst\";s:3:\"Pau\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:12:\"RAYON, Chelo\";i:1;s:13:\"RIVAS, Concha\";i:2;s:10:\"TORMO, Mar\";i:3;s:14:\"RUBIO, Vicente\";i:4;s:13:\"BUENO, Javier\";i:5;s:13:\"MANSO, F\u00e9lix\";i:6;s:15:\"MILONE, Gustavo\";i:7;s:19:\"DE LA SERNA, Javier\";i:8;s:17:\"PEREZ, Inmaculada\";i:9;s:21:\"PEREZ-ENCINAS, Manuel\";i:10;s:14:\"KRSNIK, Isabel\";i:11;s:13:\"VELLENGA, Edo\";i:12;s:15:\"RIBERA, Josep M\";i:13;s:15:\"ESCODA, Lourdes\";i:14;s:14:\"LOWENBERG, Bob\";i:15;s:14:\"SANZ, Miguel A\";i:16;s:13:\"BRUNET, Salut\";i:17;s:15:\"GONZALEZ, Jos\u00e9\";i:18;s:16:\"GONZALEZ, Marcos\";i:19;s:22:\"HOLOWIECKA, Aleksandra\";i:20;s:13:\"ESTEVE, Jordi\";i:21;s:12:\"BERGUA, Juan\";i:22;s:17:\"GONZALEZ, Jos\u00e9 D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:31:\"Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.1182\/blood-2010-04-277434\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1182\/blood-2010-04-277434\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"117\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1799\";s:8:\"\u0000*\u0000epage\";s:4:\"1805\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"MONTESINOS\";s:10:\"\u0000*\u0000aufirst\";s:3:\"Pau\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:12:\"RAYON, Chelo\";i:1;s:13:\"RIVAS, Concha\";i:2;s:10:\"TORMO, Mar\";i:3;s:14:\"RUBIO, Vicente\";i:4;s:13:\"BUENO, Javier\";i:5;s:13:\"MANSO, F\u00e9lix\";i:6;s:15:\"MILONE, Gustavo\";i:7;s:19:\"DE LA SERNA, Javier\";i:8;s:17:\"PEREZ, Inmaculada\";i:9;s:21:\"PEREZ-ENCINAS, Manuel\";i:10;s:14:\"KRSNIK, Isabel\";i:11;s:13:\"VELLENGA, Edo\";i:12;s:15:\"RIBERA, Josep M\";i:13;s:15:\"ESCODA, Lourdes\";i:14;s:14:\"LOWENBERG, Bob\";i:15;s:14:\"SANZ, Miguel A\";i:16;s:13:\"BRUNET, Salut\";i:17;s:15:\"GONZALEZ, Jos\u00e9\";i:18;s:16:\"GONZALEZ, Marcos\";i:19;s:22:\"HOLOWIECKA, Aleksandra\";i:20;s:13:\"ESTEVE, Jordi\";i:21;s:12:\"BERGUA, Juan\";i:22;s:17:\"GONZALEZ, Jos\u00e9 D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:31:\"Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1182\/blood-2010-04-277434\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"117\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1799\";s:8:\"\u0000*\u0000epage\";s:4:\"1805\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"MONTESINOS\";s:10:\"\u0000*\u0000aufirst\";s:3:\"Pau\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:12:\"RAYON, Chelo\";i:1;s:13:\"RIVAS, Concha\";i:2;s:10:\"TORMO, Mar\";i:3;s:14:\"RUBIO, Vicente\";i:4;s:13:\"BUENO, Javier\";i:5;s:13:\"MANSO, F\u00e9lix\";i:6;s:15:\"MILONE, Gustavo\";i:7;s:19:\"DE LA SERNA, Javier\";i:8;s:17:\"PEREZ, Inmaculada\";i:9;s:21:\"PEREZ-ENCINAS, Manuel\";i:10;s:14:\"KRSNIK, Isabel\";i:11;s:13:\"VELLENGA, Edo\";i:12;s:15:\"RIBERA, Josep M\";i:13;s:15:\"ESCODA, Lourdes\";i:14;s:14:\"LOWENBERG, Bob\";i:15;s:14:\"SANZ, Miguel A\";i:16;s:13:\"BRUNET, Salut\";i:17;s:15:\"GONZALEZ, Jos\u00e9\";i:18;s:16:\"GONZALEZ, Marcos\";i:19;s:22:\"HOLOWIECKA, Aleksandra\";i:20;s:13:\"ESTEVE, Jordi\";i:21;s:12:\"BERGUA, Juan\";i:22;s:17:\"GONZALEZ, Jos\u00e9 D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:31:\"Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1182\/blood-2010-04-277434\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"117\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1799\";s:8:\"\u0000*\u0000epage\";s:4:\"1805\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"MONTESINOS\";s:10:\"\u0000*\u0000aufirst\";s:3:\"Pau\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:12:\"RAYON, Chelo\";i:1;s:13:\"RIVAS, Concha\";i:2;s:10:\"TORMO, Mar\";i:3;s:14:\"RUBIO, Vicente\";i:4;s:13:\"BUENO, Javier\";i:5;s:13:\"MANSO, F\u00e9lix\";i:6;s:15:\"MILONE, Gustavo\";i:7;s:19:\"DE LA SERNA, Javier\";i:8;s:17:\"PEREZ, Inmaculada\";i:9;s:21:\"PEREZ-ENCINAS, Manuel\";i:10;s:14:\"KRSNIK, Isabel\";i:11;s:13:\"VELLENGA, Edo\";i:12;s:15:\"RIBERA, Josep M\";i:13;s:15:\"ESCODA, Lourdes\";i:14;s:14:\"LOWENBERG, Bob\";i:15;s:14:\"SANZ, Miguel A\";i:16;s:13:\"BRUNET, Salut\";i:17;s:15:\"GONZALEZ, Jos\u00e9\";i:18;s:16:\"GONZALEZ, Marcos\";i:19;s:22:\"HOLOWIECKA, Aleksandra\";i:20;s:13:\"ESTEVE, Jordi\";i:21;s:12:\"BERGUA, Juan\";i:22;s:17:\"GONZALEZ, Jos\u00e9 D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:31:\"Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
